xenin-fused peptides (University of Ulster)

N/A

Report date: 2025/06/11 10:54:43

Base Information

Drug Namexenin-fused peptides (University of Ulster)

Drug Alias Nameexendin-xenin-8 fusion peptide (University of Ulster)long-acting analog of Xenin-25 (University of Ulster)xenin-25(Lys13PAL)GIP-xenin hybrid peptide (University of Ulster)EXE-XEN +[6]

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity of Ulster

China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Ulster

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2

Inactive IndicationsN/A

Other Information

ATC CodeN/A